OCT 14, 2020 7:30 AM PDT

Self-Healing Microcapsules Make Promising Leukemia Vaccines

WRITTEN BY: Tara Fernandes

Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic system.  It is characterized by rapid, out-of-control growth of abnormal cells in these tissues and accounts for around four percent of all new cancer cases in the United States.

A recent study published in Nature Biomedical Engineering details how researchers are a step closer towards a therapeutic vaccine against leukemia. Though previous works have shown promise in preventing the development of leukemia through vaccination, the clinical performance of such experimental therapies has been underwhelming so far. In part, this is due to shortcomings of the vaccine’s delivery system.

Professor Li Yuhua, from China’s Zhujiang Hospital was among the scientists leading the study and said: "Our clinical findings revealed the high expression of EPS8 and PD-1/PD-L1 in leukemia patients, which could be respectively used as a new type of leukemia antigen and a checkpoint target for a leukemia vaccine."

The team designed a novel self-healing microcapsule that contains a cargo of epitope peptides and an antibody against PD-1. These microcapsules are made of polylactic acid, an FDA-approved biomaterial that is regarded as a reference material for injectable microparticles. What’s special about these newly-developed microcapsules is their ability to efficiently load the vaccine’s active ingredients and subsequently “self heal”, sealing them in before releasing the vaccine over a prolonged period once injected into the body.

The microcapsules performed considerably better than currently-available adjuvants in a variety of leukemia therapeutic models, highlighting their exciting potential in a clinical setting.

"With the advantages of FDA-approved polylactic acid material, convenience in preparing the vaccine formulation, diversity of vaccine components, and excellent therapeutic effect, the microcapsule-based vaccine exhibits great potential for clinical translation," said Professor Ma Guanghui from the Institute of Process Engineering (IPE) of Chinese Academy of Sciences, another author of the paper.

Sources: Nature Biomedical Engineering, Medical Xpress.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
JUN 01, 2022
Clinical & Molecular DX
Personalized Cancer Vaccine Showing Promise in Treating Melanoma and Ovarian Cancer
JUN 01, 2022
Personalized Cancer Vaccine Showing Promise in Treating Melanoma and Ovarian Cancer
Cancer vaccines have been around for decades, but a unique neoantigen vaccine called NeoVax is making researchers hopefu ...
JUN 06, 2022
Clinical & Molecular DX
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
JUN 06, 2022
Researchers Confirm the Impact of Gut Viruses on Inflammatory Bowel Disease
The gut microbiome refers to the collection of microorganisms that reside within the gut. The gut microbiome is known to ...
JUN 13, 2022
Cancer
Clinical Trial Demonstrates an Amazing 100% Response
JUN 13, 2022
Clinical Trial Demonstrates an Amazing 100% Response
The results of a Clinical Trial for rectal cancer patients published last week in the New England Journal of Medicine co ...
JUN 25, 2022
Health & Medicine
Germs Lurking in Recreational Water and How to Avoid Them
JUN 25, 2022
Germs Lurking in Recreational Water and How to Avoid Them
The National Institute of Health published its tips for water safety in the NIH News in Health June issue. This month&rs ...
JUL 08, 2022
Immunology
Solving the Mystery of Failed Staph Vaccines Shows How to Make Them Effective
JUL 08, 2022
Solving the Mystery of Failed Staph Vaccines Shows How to Make Them Effective
Some common bacteria like Staphylococcus aureus have both harmless and pathogenic versions. While staph is often harmles ...
JUL 22, 2022
Coronavirus
Researchers Say Nasal Boosters Will be Important to Stopping COVID
JUL 22, 2022
Researchers Say Nasal Boosters Will be Important to Stopping COVID
The SARS-CoV-2 virus has continued to evolve since the start of the pandemic, and we've moved down the list of variants ...
Loading Comments...